Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

20 May 2003

The acute hepatitis as a form of the liver manifestation of chronic GvHD

Z. Michalska, P. Stalke, K. Witczak-Malinowska, E. Lakomy, K. Sikorska, J. Stolarczyk, H. Trocha

Med Sci Monit 2003; 9(2): 12-0 :: ID: 15263

Abstract

During 12 months after allogenic bone marrow transplantation abnormal liver function tests are observed in the majority of patients.In our study we observed 4 patients (3 males and 1 female)aged 36 –44 years,mean 40 with symptoms of cholestatic acute hepatitis after allogenic bone marrow transplantation due to chronic myeloid leukaemia.These patients were admitted to the hospital with suspicion of acute viral hepatitis.The allogenic bone marrow transplantation was performed 120 –450 days (mean 223)before admission to hospital.In all cases we observed classical ’symptoms of GvHD (cutaneus eruption,mucosal erosions and pulmonary fibrosis) before symptoms of liver injury appeared.Viral hepatitis (HAV,HBV,HCV,CMV)and liver damage due to bacterial or fungal infection and drug toxicity were excluded.The mean value of liver function tests were as follow:ALT 1410 IU/l, bilirubin 2.5 mg/dl,Alkaline phosphatase 272 IU/l,GGT 499 IU/l.Histopatologic examinations of liver biopsy specimens revealed parenhymal necrosis with lymphocytic infiltration of partial zones and perivascular, periportal fibrosis.In liver samples the typical changes of GvHD in small bile ducts were found.In all cases immunosupressive therapy (corticoids, cyclosporine)was effective. Conclusions: The acute hepatitis as a form of liver manifestation of chronic GvHD should be taken under consideration during diagnosis of acute viral hepatitis after bone marrow transplantation in patients on mild immunosupression. High-dose immunosupression seems to prevent the progression of intrahepatic bile ducts ’destruction effectively.Liver biopsy is crucial in diagnosis of GvHD.

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750